September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Biagio Ricciuti: MET kinase domain mutations as novel and targetable alterations in NSCLC
Apr 8, 2024, 23:10

Biagio Ricciuti: MET kinase domain mutations as novel and targetable alterations in NSCLC

Biagio Ricciuti, Medical oncologist at Dana-Farber Cancer Institute, shared a post on LinkedIn:

“Our collaborative effort to characterize MET kinase domain mutations as novel and targetable alterations in NSCLC and other cancer types is out in Cancer Discovery AACR Journals. In this study led by our stellar scientists Federica Pecci and Shesiru Nakazawa we identified that activating MET TKD mutations occur in multiple malignancies and can confer clinical sensitivity to currently available MET inhibitors. This study highlights the importance of performing comprehensive genomic tumor profiling to detect rare but targetable drivers.”

Read further.
Source: Biagio Ricciuti/LinkedIn